Correlation Between Sarepta Therapeutics and Sonnet Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Sarepta Therapeutics and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarepta Therapeutics and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sarepta Therapeutics and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Sarepta Therapeutics and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarepta Therapeutics with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarepta Therapeutics and Sonnet Biotherapeutics.
Diversification Opportunities for Sarepta Therapeutics and Sonnet Biotherapeutics
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Sarepta and Sonnet is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Sarepta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarepta Therapeutics are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Sarepta Therapeutics i.e., Sarepta Therapeutics and Sonnet Biotherapeutics go up and down completely randomly.
Pair Corralation between Sarepta Therapeutics and Sonnet Biotherapeutics
Given the investment horizon of 90 days Sarepta Therapeutics is expected to generate 0.5 times more return on investment than Sonnet Biotherapeutics. However, Sarepta Therapeutics is 2.0 times less risky than Sonnet Biotherapeutics. It trades about 0.14 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.29 per unit of risk. If you would invest 11,248 in Sarepta Therapeutics on September 14, 2024 and sell it today you would earn a total of 1,199 from holding Sarepta Therapeutics or generate 10.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sarepta Therapeutics vs. Sonnet Biotherapeutics Holding
Performance |
| Timeline |
| Sarepta Therapeutics |
| Sonnet Biotherapeutics |
Sarepta Therapeutics and Sonnet Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sarepta Therapeutics and Sonnet Biotherapeutics
The main advantage of trading using opposite Sarepta Therapeutics and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarepta Therapeutics position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.| Sarepta Therapeutics vs. Puma Biotechnology | Sarepta Therapeutics vs. Iovance Biotherapeutics | Sarepta Therapeutics vs. Day One Biopharmaceuticals | Sarepta Therapeutics vs. Inozyme Pharma |
| Sonnet Biotherapeutics vs. Puma Biotechnology | Sonnet Biotherapeutics vs. Iovance Biotherapeutics | Sonnet Biotherapeutics vs. Day One Biopharmaceuticals | Sonnet Biotherapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| CEOs Directory Screen CEOs from public companies around the world |